drospirenone and ethinyl estradiol combination and Cardiovascular Diseases

drospirenone and ethinyl estradiol combination has been researched along with Cardiovascular Diseases in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	4 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bodur, S; Dundar, O; Kanat-Pektas, M; Kinci, MF; Tutuncu, L	1
Shapiro, S	1
Apa, R; Ciardulli, A; Cosentino, N; Crea, F; Familiari, A; Lanzone, A; Liuzzo, G; Martinez, D; Morciano, A; Moro, F; Niccoli, G; Palla, C; Sagnella, F; Scarinci, E; Tritarelli, A; Tropea, A	1
Battaglia, C; Busacchi, P; Fabbri, R; Facchinetti, F; Mancini, F; Persico, N; Venturoli, S	1

Trials

3 trial(s) available for drospirenone and ethinyl estradiol combination and Cardiovascular Diseases

Article	Year
The effects of different therapeutic modalities on cardiovascular risk factors in women with polycystıc ovary syndrome: A randomızed controlled study. Taiwanese journal of obstetrics & gynecology, 2018, Volume: 57, Issue:3 Topics: Adult; Androstenes; Apolipoproteins B; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Drug Therapy, Combination; Ethinyl Estradiol; Female; Homocysteine; Humans; Hypoglycemic Agents; Insulin Resistance; Metabolic Syndrome; Metformin; Mineralocorticoid Receptor Antagonists; Peptide Fragments; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Reproductive Control Agents; Risk Factors; Young Adult	2018
Effects of drospirenone-ethinylestradiol and/or metformin on CD4(+)CD28(null) T lymphocytes frequency in women with hyperinsulinemia having polycystic ovary syndrome: a randomized clinical trial. Reproductive sciences (Thousand Oaks, Calif.), 2013, Volume: 20, Issue:12 Topics: Adolescent; Adult; Analysis of Variance; Androstenes; Cardiovascular Diseases; CD28 Antigens; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Chi-Square Distribution; Ethinyl Estradiol; Female; Humans; Hyperinsulinism; Hypoglycemic Agents; Metformin; Polycystic Ovary Syndrome; Reproductive Control Agents; Risk Factors; Rome; Time Factors; Treatment Outcome; Young Adult	2013
Polycystic ovary syndrome and cardiovascular risk in young patients treated with drospirenone-ethinylestradiol or contraceptive vaginal ring. A prospective, randomized, pilot study. Fertility and sterility, 2010, Volume: 94, Issue:4 Topics: Adult; Androstenes; Blood Pressure; Brachial Artery; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Contraception; Contraceptive Devices, Female; Ethinyl Estradiol; Female; Humans; Insulin; Ovary; Pilot Projects; Polycystic Ovary Syndrome; Regional Blood Flow; Risk Factors; Ultrasonography; Young Adult	2010

Other Studies

1 other study(ies) available for drospirenone and ethinyl estradiol combination and Cardiovascular Diseases

Article	Year
Combined hormonal contraceptives and the risk of venous and arterial thromboembolism and cardiovascular death: misuse of automated databases. The journal of family planning and reproductive health care, 2013, Volume: 39, Issue:2 Topics: Androstenes; Bias; Cardiovascular Diseases; Confounding Factors, Epidemiologic; Contraceptives, Oral, Combined; Data Interpretation, Statistical; Databases, Factual; Ethinyl Estradiol; Female; Humans; Risk Factors; Thromboembolism; Venous Thromboembolism	2013

Article

Year

Combined hormonal contraceptives and the risk of venous and arterial thromboembolism and cardiovascular death: misuse of automated databases.

The journal of family planning and reproductive health care, 2013, Volume: 39, Issue:2

Topics: Androstenes; Bias; Cardiovascular Diseases; Confounding Factors, Epidemiologic; Contraceptives, Oral, Combined; Data Interpretation, Statistical; Databases, Factual; Ethinyl Estradiol; Female; Humans; Risk Factors; Thromboembolism; Venous Thromboembolism

2013